Variant report
Variant | nsv970653 |
---|---|
Chromosome Location | chr6:15826001-15833990 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:8)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:8 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:15816794..15818788-chr6:15829882..15831801,2 | K562 | blood: | |
2 | chr6:15825494..15828253-chr6:15836112..15838842,2 | K562 | blood: | |
3 | chr6:15825711..15828125-chr6:16131574..16133261,2 | K562 | blood: | |
4 | chr6:15832653..15834259-chr6:15835563..15837751,2 | K562 | blood: | |
5 | chr6:15823997..15826089-chr6:16129205..16131179,2 | K562 | blood: | |
6 | chr6:15832759..15836076-chr6:15836217..15838257,3 | K562 | blood: | |
7 | chr6:15829716..15831885-chr6:16127780..16130244,2 | K562 | blood: | |
8 | chr6:15822836..15825669-chr6:15827542..15830932,3 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000007944 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs35563909 | chr6:15826053-15826054 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs147278362 | chr6:15826071-15826072 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs539071652 | chr6:15826134-15826135 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs220882 | chr6:15826170-15826171 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
5 | rs368318811 | chr6:15826182-15826183 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs562820497 | chr6:15826209-15826210 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs189662258 | chr6:15826216-15826217 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs551476135 | chr6:15826222-15826223 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs74593262 | chr6:15826226-15826227 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs527944417 | chr6:15826227-15826228 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs181340020 | chr6:15826247-15826248 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs140691397 | chr6:15826288-15826289 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs35462833 | chr6:15826290-15826291 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs144654786 | chr6:15826291-15826292 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs556320375 | chr6:15826307-15826308 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs186552340 | chr6:15826354-15826355 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs116121193 | chr6:15826383-15826384 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs58657296 | chr6:15826401-15826402 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs151324471 | chr6:15826407-15826408 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs139436018 | chr6:15826434-15826435 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs576890780 | chr6:15826436-15826437 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs554357737 | chr6:15826473-15826474 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs569175305 | chr6:15826552-15826553 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs574263468 | chr6:15826588-15826589 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs543199397 | chr6:15826596-15826597 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs543576536 | chr6:15826597-15826598 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs563041535 | chr6:15826609-15826610 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs576456176 | chr6:15826616-15826617 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs191005450 | chr6:15826663-15826664 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs565096348 | chr6:15826716-15826717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs79148410 | chr6:15826755-15826756 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs72653738 | chr6:15826756-15826757 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs199518952 | chr6:15826757-15826758 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs372255179 | chr6:15826807-15826808 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs531703709 | chr6:15826921-15826922 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs74464711 | chr6:15826993-15826994 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs200554692 | chr6:15827011-15827012 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs528009701 | chr6:15827028-15827029 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs573537295 | chr6:15827035-15827036 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs373274371 | chr6:15827121-15827122 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs150063061 | chr6:15827157-15827158 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs561545879 | chr6:15827171-15827172 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs183726946 | chr6:15827211-15827212 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs13190874 | chr6:15827242-15827243 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs220883 | chr6:15827303-15827304 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs538306719 | chr6:15827376-15827377 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs4716000 | chr6:15827422-15827423 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs188253816 | chr6:15827503-15827504 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs545096463 | chr6:15827509-15827510 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs191137136 | chr6:15827517-15827518 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 20164920 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Bladder cancer | 21909424 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 16790693 | CNVD |
Breast cancer | 22032731 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21785460 | CNVD |
Bladder cancer | 16790693 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17142309 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Developmental delay | 19490664 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:15824200-15826800 | Weak transcription | K562 | blood |
2 | chr6:15824200-15828000 | Weak transcription | Fetal Heart | heart |
3 | chr6:15825800-15842800 | Weak transcription | Right Atrium | heart |
4 | chr6:15826000-15826600 | Enhancers | Fetal Brain Male | brain |
5 | chr6:15826800-15828800 | Enhancers | K562 | blood |
6 | chr6:15827200-15827400 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
7 | chr6:15828000-15828600 | Enhancers | Fetal Heart | heart |
8 | chr6:15828200-15828600 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
9 | chr6:15828600-15829000 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
10 | chr6:15828800-15830000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
11 | chr6:15828800-15830200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
12 | chr6:15829000-15830000 | Enhancers | Primary hematopoietic stem cells | blood |
13 | chr6:15829000-15830200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
14 | chr6:15832000-15832200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |